**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: January 15, 1980
* Admission Date: March 10, 2023
* Discharge Date: March 20, 2023

**Admission Diagnosis:**

* Type 2 Diabetes Mellitus

**Clinical Course:**

John Doe, a 43-year-old male, was admitted to the endocrinology unit on March 10, 2023, with a diagnosis of type 2 diabetes mellitus. He presented with symptoms of increased thirst and urination, as well as fatigue and blurred vision. The patient's medical history included hypertension, hyperlipidemia, and a 10-year history of smoking.

**Diagnostic Evaluation:**

Upon admission, the patient underwent a comprehensive diagnostic evaluation, which included:

* Fasting plasma glucose (FPG) levels: 240 mg/dL
* Glycosylated hemoglobin (HbA1C) test: 7.5%
* Random glucose value: 250 mg/dL
* Lipid profile: total cholesterol 220 mg/dL, LDL 140 mg/dL, HDL 40 mg/dL
* Kidney function tests: serum creatinine 1.2 mg/dL, urine albumin-to-creatinine ratio 30 mg/g

**Treatment:**

The patient was started on a comprehensive treatment plan, which included:

* Metformin 500 mg twice daily, initiated on March 12, 2023
* Diet and exercise counseling, focusing on whole foods, high-quality carbohydrates, and regular physical activity
* Patient education on managing blood glucose levels, recognizing symptoms and signs of hypoglycemia and hyperglycemia, and adjusting insulin doses based on blood glucose levels and carbohydrate intake
* Regular monitoring of blood glucose levels, HbA1C, and kidney function tests

**Medications:**

* Metformin 500 mg twice daily, continued at discharge
* Aspirin 81 mg daily, initiated on March 15, 2023, for cardiovascular risk reduction

**Discharge Instructions:**

The patient was discharged on March 20, 2023, with the following instructions:

* Continue metformin 500 mg twice daily
* Monitor blood glucose levels at home and report any changes to the healthcare provider
* Adjust diet and exercise plan as needed to achieve target blood glucose levels
* Attend regular follow-up appointments with the healthcare provider
* Follow up with a podiatrist for regular foot care
* Receive vaccinations against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2

**Next Steps:**

The patient will need to follow up with the healthcare provider in 2 weeks to monitor blood glucose levels and adjust the treatment plan as needed. The patient will also need to schedule follow-up appointments with a podiatrist and a cardiologist to monitor for any cardiovascular complications.

**Conclusion:**

John Doe, a 43-year-old male with type 2 diabetes mellitus, was admitted to the endocrinology unit and received a comprehensive treatment plan, including metformin, diet and exercise counseling, and patient education. The patient was discharged with a plan for regular follow-up appointments and vaccinations.